Open-label, randomized study of pegfilgrastim vs. daily filgrastim as an adjunct to chemotherapy in elderly patients with non-Hodgkin's lymphoma.

Saved in:
Bibliographic Details
Title: Open-label, randomized study of pegfilgrastim vs. daily filgrastim as an adjunct to chemotherapy in elderly patients with non-Hodgkin's lymphoma.
Authors: Grigg A; Department of Clinical Haematology and Oncology, Royal Melbourne Hospital, Melbourne, Australia. andrew.grigg@mh.org.au, Solal-Celigny P, Hoskin P, Taylor K, McMillan A, Forstpointner R, Bacon P, Renwick J, Hiddemann W
Corporate Authors: International Study Group
Source: Leukemia & lymphoma [Leuk Lymphoma] 2003 Sep; Vol. 44 (9), pp. 1503-8.
Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print Cited Medium: Print ISSN: 1042-8194 (Print) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1042-8194
DOI:10.1080/1042819031000103953